跳至主要内容
临床试验/IRCT2012120711647N1
IRCT2012120711647N1已完成2 期

Comparison of success of trabeculectomy in glaucoma patients treated with trabeculectomy alone versus adjunctive intracameral bevacizumab-combined trabeculectomy: A clinical trial

Vice chancellor for research, Tehran University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 99 years(—)
性别
All

入选标准

  • Inclusion Criteria: Primary open angle or pseudoexfoliative glaucoma patients 65 years or older who are candidates of standard trabeculectomy procedure (whose optic nerve function is failing or is likely to fail and is already on the maximum tolerated medical therapy and not likely to achieve a sufficient lOP reduction with laser treatment).
  • Exclusion criteria: Patients at high risk of failure of trabeculectomy, including aphakic, pseudophakic, uveitic, neovascular and juvenile glaucoma.

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Tehran University of Medical Sciences

相似试验

The effect of bevacizumab on success of... | 临床试验